Bill Mulholland’s practice is concentrated in intellectual property law, including patent, copyright, and trademark licensing, litigation and procurement. His past experience includes serving as in-house counsel for pharmaceutical and agribusiness-based industries. A substantial portion of Bill’s practice involves strategic counseling for these industries, including all IP-related aspects of discovery, development and commercialization activities.
Bill has extensive transactional experience and has negotiated a wide range of licenses and other agreements in support of various industry and university alliances. His patent procurement practice includes comprehensive life-cycle management planning, from emerging technologies to post-patent expiry of commercial products. Bill’s life sciences practice includes small molecule chemistry and biologic therapeutics, as well as diagnostics, drug discovery and drug delivery. His agribusiness practice similarly focuses on chemical and biologic-based active ingredients, as well as formulation and chemical process technologies.
Bill serves as co-chair of Snell & Wilmer's Life Sciences and Medical Technology group.
